Section of Cancer Information, International Agency for Research on Cancer (IARC), France.
Eur J Cancer. 2013 Apr;49(6):1374-403. doi: 10.1016/j.ejca.2012.12.027. Epub 2013 Feb 26.
Cancer incidence and mortality estimates for 25 cancers are presented for the 40 countries in the four United Nations-defined areas of Europe and for the European Union (EU-27) for 2012.
We used statistical models to estimate national incidence and mortality rates in 2012 from recently-published data, predicting incidence and mortality rates for the year 2012 from recent trends, wherever possible. The estimated rates in 2012 were applied to the corresponding population estimates to obtain the estimated numbers of new cancer cases and deaths in Europe in 2012.
There were an estimated 3.45 million new cases of cancer (excluding non-melanoma skin cancer) and 1.75 million deaths from cancer in Europe in 2012. The most common cancer sites were cancers of the female breast (464,000 cases), followed by colorectal (447,000), prostate (417,000) and lung (410,000). These four cancers represent half of the overall burden of cancer in Europe. The most common causes of death from cancer were cancers of the lung (353,000 deaths), colorectal (215,000), breast (131,000) and stomach (107,000). In the European Union, the estimated numbers of new cases of cancer were approximately 1.4 million in males and 1.2 million in females, and around 707,000 men and 555,000 women died from cancer in the same year.
These up-to-date estimates of the cancer burden in Europe alongside the description of the varying distribution of common cancers at both the regional and country level provide a basis for establishing priorities to cancer control actions in Europe. The important role of cancer registries in disease surveillance and in planning and evaluating national cancer plans is becoming increasingly recognised, but needs to be further advocated. The estimates and software tools for further analysis (EUCAN 2012) are available online as part of the European Cancer Observatory (ECO) (http://eco.iarc.fr).
本研究报告提供了 2012 年欧洲四个联合国定义地区和欧盟(EU-27)40 个国家的 25 种癌症的发病和死亡估计数据。
我们使用统计模型,根据最新发表的数据对 2012 年的国家发病率和死亡率进行了估计,尽可能根据近期趋势预测 2012 年的发病率和死亡率。2012 年的估计发病率被应用于相应的人口估计数,以获得 2012 年欧洲新癌症病例和死亡人数的估计数。
2012 年欧洲估计有 345 万例(不包括非黑素瘤皮肤癌)新癌症病例和 175 万例癌症死亡。最常见的癌症部位是女性乳腺癌(464,000 例),其次是结直肠癌(447,000 例)、前列腺癌(417,000 例)和肺癌(410,000 例)。这四种癌症占欧洲癌症总负担的一半。癌症死亡的最常见原因是肺癌(353,000 人死亡)、结直肠癌(215,000 人死亡)、乳腺癌(131,000 人死亡)和胃癌(107,000 人死亡)。在欧盟,估计男性新癌症病例数约为 140 万,女性约为 120 万,同年有 70.7 万男性和 55.5 万女性死于癌症。
这些最新的欧洲癌症负担估计数据,以及对区域和国家层面常见癌症分布差异的描述,为欧洲制定癌症控制行动的优先事项提供了依据。癌症登记处在疾病监测以及国家癌症计划的规划和评估方面的重要作用越来越受到认可,但仍需要进一步提倡。进一步分析的估计数据和软件工具(EUCAN 2012)可作为欧洲癌症观察站(ECO)(http://eco.iarc.fr)的一部分在线获取。